No Cover Image

Book 247 views

Grand Challenges in Algae Biotechnology / Carole Llewellyn, Rahul Kapoore, Robert Lovitt, Carolyn Greig, Claudio Fuentes Grunewald, Bethan Kultschar

Grand Challenges in Biology and Biotechnology, Issue: 8, Pages: 535 - 576

Swansea University Authors: Carole Llewellyn, Rahul Kapoore, Robert Lovitt, Carolyn Greig, Claudio Fuentes Grunewald, Bethan Kultschar

Full text not available from this repository: check for access using links below.

Abstract

This chapter focuses on the challenges associated with achieving economic value from metabolites derived from cyanobacteria. Significant advances have been made in cyanobacterial biotechnology in the last few years. However, the field is still immature, and many challenges remain. We start with a cr...

Full description

Published in: Grand Challenges in Biology and Biotechnology
ISBN: 9783030252328 9783030252335
ISSN: 2367-1017 2367-1025
Published: Cham Springer International Publishing 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa53142
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2020-01-07T19:46:45Z
last_indexed 2020-09-17T03:16:17Z
id cronfa53142
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2020-01-07T16:15:55.8418740</datestamp><bib-version>v2</bib-version><id>53142</id><entry>2020-01-07</entry><title>Grand Challenges in Algae Biotechnology</title><swanseaauthors><author><sid>bcd94bda79ebf4c2c82d82dfb027a140</sid><ORCID/><firstname>Carole</firstname><surname>Llewellyn</surname><name>Carole Llewellyn</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>5583be4600daecd670edac16f6e77e88</sid><ORCID>0000-0002-2287-0619</ORCID><firstname>Rahul</firstname><surname>Kapoore</surname><name>Rahul Kapoore</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>130c3c35f45826bb0f4836305e8e51c7</sid><firstname>Robert</firstname><surname>Lovitt</surname><name>Robert Lovitt</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>7f95061328bd6726f7472ced9cb8d937</sid><firstname>Carolyn</firstname><surname>Greig</surname><name>Carolyn Greig</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>8d7cf97e82178c021883618d24acb4b4</sid><ORCID>0000-0002-3122-9452</ORCID><firstname>Claudio</firstname><surname>Fuentes Grunewald</surname><name>Claudio Fuentes Grunewald</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>cf46ac75279669d639919148dca4f741</sid><firstname>Bethan</firstname><surname>Kultschar</surname><name>Bethan Kultschar</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-01-07</date><deptcode>SBI</deptcode><abstract>This chapter focuses on the challenges associated with achieving economic value from metabolites derived from cyanobacteria. Significant advances have been made in cyanobacterial biotechnology in the last few years. However, the field is still immature, and many challenges remain. We start with a critical overview of the main technologies associated with cultivation, cell disruption and metabolite extraction. Then, we provide an overview of current significant metabolite groups from cyanobacteria relevant to industry covering phycobilins, carotenoids, polysaccharides, peptides, lipids, mycosporine-like amino acids, polyhydroxyalkanoates, cyanotoxins and platform chemicals, and the potential for stable isotopes production. We cover metabolites that are already in the market and those with future potential with a focus on spirulina (Arthrospira) the most commercially developed species of cyanobacteria. As large-scale cultivation and down-stream processing techniques continue to develop further, combining this with a systems biology and biorefinery approach will ensure that the best economic and environmental sustainability value can be achieved.</abstract><type>Book</type><journal>Grand Challenges in Biology and Biotechnology</journal><journalNumber>8</journalNumber><paginationStart>535</paginationStart><paginationEnd>576</paginationEnd><publisher>Springer International Publishing</publisher><placeOfPublication>Cham</placeOfPublication><isbnPrint>9783030252328</isbnPrint><isbnElectronic>9783030252335</isbnElectronic><issnPrint>2367-1017</issnPrint><issnElectronic>2367-1025</issnElectronic><keywords/><publishedDay>3</publishedDay><publishedMonth>1</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-01-03</publishedDate><doi>10.1007/978-3-030-25233-5</doi><url>http://dx.doi.org/10.1007/978-3-030-25233-5</url><notes/><college>COLLEGE NANME</college><department>Biosciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>SBI</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-01-07T16:15:55.8418740</lastEdited><Created>2020-01-07T16:15:55.8418740</Created><authors><author><firstname>Carole</firstname><surname>Llewellyn</surname><orcid/><order>1</order></author><author><firstname>Rahul</firstname><surname>Kapoore</surname><orcid>0000-0002-2287-0619</orcid><order>2</order></author><author><firstname>Robert</firstname><surname>Lovitt</surname><order>3</order></author><author><firstname>Carolyn</firstname><surname>Greig</surname><order>4</order></author><author><firstname>Claudio</firstname><surname>Fuentes Grunewald</surname><orcid>0000-0002-3122-9452</orcid><order>5</order></author><author><firstname>Bethan</firstname><surname>Kultschar</surname><order>6</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2020-01-07T16:15:55.8418740 v2 53142 2020-01-07 Grand Challenges in Algae Biotechnology bcd94bda79ebf4c2c82d82dfb027a140 Carole Llewellyn Carole Llewellyn true false 5583be4600daecd670edac16f6e77e88 0000-0002-2287-0619 Rahul Kapoore Rahul Kapoore true false 130c3c35f45826bb0f4836305e8e51c7 Robert Lovitt Robert Lovitt true false 7f95061328bd6726f7472ced9cb8d937 Carolyn Greig Carolyn Greig true false 8d7cf97e82178c021883618d24acb4b4 0000-0002-3122-9452 Claudio Fuentes Grunewald Claudio Fuentes Grunewald true false cf46ac75279669d639919148dca4f741 Bethan Kultschar Bethan Kultschar true false 2020-01-07 SBI This chapter focuses on the challenges associated with achieving economic value from metabolites derived from cyanobacteria. Significant advances have been made in cyanobacterial biotechnology in the last few years. However, the field is still immature, and many challenges remain. We start with a critical overview of the main technologies associated with cultivation, cell disruption and metabolite extraction. Then, we provide an overview of current significant metabolite groups from cyanobacteria relevant to industry covering phycobilins, carotenoids, polysaccharides, peptides, lipids, mycosporine-like amino acids, polyhydroxyalkanoates, cyanotoxins and platform chemicals, and the potential for stable isotopes production. We cover metabolites that are already in the market and those with future potential with a focus on spirulina (Arthrospira) the most commercially developed species of cyanobacteria. As large-scale cultivation and down-stream processing techniques continue to develop further, combining this with a systems biology and biorefinery approach will ensure that the best economic and environmental sustainability value can be achieved. Book Grand Challenges in Biology and Biotechnology 8 535 576 Springer International Publishing Cham 9783030252328 9783030252335 2367-1017 2367-1025 3 1 2020 2020-01-03 10.1007/978-3-030-25233-5 http://dx.doi.org/10.1007/978-3-030-25233-5 COLLEGE NANME Biosciences COLLEGE CODE SBI Swansea University 2020-01-07T16:15:55.8418740 2020-01-07T16:15:55.8418740 Carole Llewellyn 1 Rahul Kapoore 0000-0002-2287-0619 2 Robert Lovitt 3 Carolyn Greig 4 Claudio Fuentes Grunewald 0000-0002-3122-9452 5 Bethan Kultschar 6
title Grand Challenges in Algae Biotechnology
spellingShingle Grand Challenges in Algae Biotechnology
Carole, Llewellyn
Rahul, Kapoore
Robert, Lovitt
Carolyn, Greig
Claudio, Fuentes Grunewald
Bethan, Kultschar
title_short Grand Challenges in Algae Biotechnology
title_full Grand Challenges in Algae Biotechnology
title_fullStr Grand Challenges in Algae Biotechnology
title_full_unstemmed Grand Challenges in Algae Biotechnology
title_sort Grand Challenges in Algae Biotechnology
author_id_str_mv bcd94bda79ebf4c2c82d82dfb027a140
5583be4600daecd670edac16f6e77e88
130c3c35f45826bb0f4836305e8e51c7
7f95061328bd6726f7472ced9cb8d937
8d7cf97e82178c021883618d24acb4b4
cf46ac75279669d639919148dca4f741
author_id_fullname_str_mv bcd94bda79ebf4c2c82d82dfb027a140_***_Carole, Llewellyn
5583be4600daecd670edac16f6e77e88_***_Rahul, Kapoore
130c3c35f45826bb0f4836305e8e51c7_***_Robert, Lovitt
7f95061328bd6726f7472ced9cb8d937_***_Carolyn, Greig
8d7cf97e82178c021883618d24acb4b4_***_Claudio, Fuentes Grunewald
cf46ac75279669d639919148dca4f741_***_Bethan, Kultschar
author Carole, Llewellyn
Rahul, Kapoore
Robert, Lovitt
Carolyn, Greig
Claudio, Fuentes Grunewald
Bethan, Kultschar
author2 Carole Llewellyn
Rahul Kapoore
Robert Lovitt
Carolyn Greig
Claudio Fuentes Grunewald
Bethan Kultschar
format Book
container_title Grand Challenges in Biology and Biotechnology
container_issue 8
container_start_page 535
publishDate 2020
institution Swansea University
isbn 9783030252328
9783030252335
issn 2367-1017
2367-1025
doi_str_mv 10.1007/978-3-030-25233-5
publisher Springer International Publishing
url http://dx.doi.org/10.1007/978-3-030-25233-5
document_store_str 0
active_str 0
description This chapter focuses on the challenges associated with achieving economic value from metabolites derived from cyanobacteria. Significant advances have been made in cyanobacterial biotechnology in the last few years. However, the field is still immature, and many challenges remain. We start with a critical overview of the main technologies associated with cultivation, cell disruption and metabolite extraction. Then, we provide an overview of current significant metabolite groups from cyanobacteria relevant to industry covering phycobilins, carotenoids, polysaccharides, peptides, lipids, mycosporine-like amino acids, polyhydroxyalkanoates, cyanotoxins and platform chemicals, and the potential for stable isotopes production. We cover metabolites that are already in the market and those with future potential with a focus on spirulina (Arthrospira) the most commercially developed species of cyanobacteria. As large-scale cultivation and down-stream processing techniques continue to develop further, combining this with a systems biology and biorefinery approach will ensure that the best economic and environmental sustainability value can be achieved.
published_date 2020-01-03T04:16:46Z
_version_ 1722083292342124544
score 10.851168